Moreover, the higher expression of iNOS in ovarian cancer specimens can predict poor prognosis, supporting the idea of the iNOS as a helpful prognostic marker and a potential therapeutic target for ovary cancer. The gene discussed is NOS2; the disease is ovarian cancer.